Ruxolitinib Produces Durable Improvements In Patients With Myelofibrosis
ATLANTA – Ruxolitinib reduces splenomegaly and other symptoms commonly associated with myelofibrosis, and the results are maintained for at
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓